Skip to main content
Fig. 5 | The Journal of Headache and Pain

Fig. 5

From: Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study

Fig. 5

Proportion of patients with a 100% reduction in monthly migraine/headache days. Black bars: patients from headache centers providing data at weeks 12 and 24 (n = 148). Hatched bars: patients from headache centers providing data at weeks 4, 8, 12, 16, 20 and 24 (n = 89). HFEM: high-frequency episodic migraine; CM: chronic migraine

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us